NeuroScientific Biopharmaceuticals Ltd
ASX:NSB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
NeuroScientific Biopharmaceuticals Ltd
ASX:NSB
|
AU |
|
Trip.com Group Ltd
F:CLVB
|
SG |
|
S
|
Superior Prima Sukses PT Tbk
IDX:BLES
|
ID |
|
Rapport Therapeutics Inc
NASDAQ:RAPP
|
US |
|
D
|
DHSteel
KOSDAQ:021045
|
KR |
|
L
|
Latrobe Magnesium Ltd
F:L2Q
|
AU |
|
Kewpie Corp
F:QPJ
|
JP |
|
Ipsos SA
F:IPZ
|
FR |
|
C
|
CopperCorp Resources Inc
F:NU0
|
CA |
|
Mega Uranium Ltd
OTC:MGAFF
|
CA |
|
QMines Ltd
ASX:QML
|
AU |
|
A
|
Apnimed Inc
NASDAQ:APMD
|
US |
Shareholder Yield
Current shareholder yield for NSB is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
NSB Price
NeuroScientific Biopharmaceuticals Ltd
| Average Annual Return | 6.71% |
| Standard Deviation of Annual Returns | 127.68% |
| Max Drawdown | -92% |
| Market Capitalization | 22.6m AUD |
| Shares Outstanding | 389 720 000 |
| Percentage of Shares Shorted |
N/A
|
